These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22679045)

  • 1. Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir.
    Das P; Vivek V; Ford M; Kingdon E; Holt S
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22679045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine.
    Okuse C; Yotsuyanagi H; Yamada N; Ikeda H; Takahashi H; Suzuki M; Kondo S; Kimura K; Koike J; Itoh F
    Clin Nephrol; 2006 Jan; 65(1):53-6. PubMed ID: 16429843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?
    Trojan J; Stuermer M; Teuber G; Berger A; Faust D
    Gut; 2007 Mar; 56(3):436-7; author reply 437. PubMed ID: 17339249
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including Lamivudine-resistant strains.
    Sun IO; Hong YA; Park HS; Choi SR; Chung BH; Park CW; Yang CW; Kim YS; Choi BS
    Korean J Intern Med; 2012 Dec; 27(4):411-6. PubMed ID: 23269882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.
    Núñez M; Pérez-Olmeda M; Díaz B; Ríos P; González-Lahoz J; Soriano V
    AIDS; 2002 Nov; 16(17):2352-4. PubMed ID: 12441815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
    Benhamou Y; Poynard T
    J Hepatol; 2003; 39 Suppl 1():S194-9. PubMed ID: 14708703
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.
    Jones J; Colquitt J; Shepherd J; Harris P; Cooper K
    Health Technol Assess; 2010 May; 14 Suppl 1():23-9. PubMed ID: 20507800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy.
    Chuang TW; Hung CH; Huang SC; Lee CM
    J Formos Med Assoc; 2007 Oct; 106(10):869-73. PubMed ID: 17964968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare.
    Stornaiuolo G; Brancaccio G; Precone V; Sgrò G; Nardiello S; Gaeta GB
    Infez Med; 2009 Jun; 17(2):105-8. PubMed ID: 19602924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Another case of HBV associated membranous glomerulonephritis resolving on lamivudine.
    Filler G; Feber J; Weiler G; Le Saux N
    Arch Dis Child; 2003 May; 88(5):460. PubMed ID: 12716731
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of tenofovir-based rescue therapy for chronic hepatitis B patients with previous nucleo(s/t)ide treatment failure.
    Lee CI; Kwon SY; Kim JH; Choe WH; Lee CH; Yoon EL; Yeon JE; Byun KS; Kim YS; Kim JH
    Gut Liver; 2014 Jan; 8(1):64-9. PubMed ID: 24516703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
    Ong A; Wong VW; Wong GL; Chan HY; Tse CH; Chan HL
    Aliment Pharmacol Ther; 2011 Oct; 34(8):972-81. PubMed ID: 21883327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis.
    Choe WH; Kwon SY; Kim BK; Ko SY; Yeon JE; Byun KS; Kim GH; Lee CH
    Liver Int; 2008 Jul; 28(6):814-20. PubMed ID: 18312291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease.
    Ebata S; Hashimoto S; Suzuki A; Ito M; Maoka T; Ishikawa Y; Mochizuki T; Koike T
    Clin Exp Nephrol; 2012 Oct; 16(5):805-10. PubMed ID: 22911115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
    Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
    Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of adefovir & lamivudine in chronic hepatitis B: correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis.
    Pradeep Kumar S; Medhi S; Asim M; Das BC; Gondal R; Kar P
    Indian J Med Res; 2011 Jan; 133(1):50-6. PubMed ID: 21321419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant of hepatitis B virus with primary resistance to adefovir.
    Schildgen O; Sirma H; Funk A; Olotu C; Wend UC; Hartmann H; Helm M; Rockstroh JK; Willems WR; Will H; Gerlich WH
    N Engl J Med; 2006 Apr; 354(17):1807-12. PubMed ID: 16641397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine.
    Delaugerre C; Marcelin AG; Thibault V; Peytavin G; Bombled T; Bochet MV; Katlama C; Benhamou Y; Calvez V
    Antimicrob Agents Chemother; 2002 May; 46(5):1586-8. PubMed ID: 11959607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures.
    Kim YJ; Sinn DH; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC; Lee JH
    World J Gastroenterol; 2012 Dec; 18(47):6996-7002. PubMed ID: 23322999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.